Larry Papasan - Reaves Utility Independent Trustee
| UTG Fund | USD 34.39 0.50 1.48% |
Mr. Larry W. Papasan is Independent Trustee of the Company. Mr. Papasan is currently a Trustee or Director of Mimedx, Inc. AxioMed Spine, BioMedical Tissues Technologies, Bionova, Inc., and MEDOVEX Corporationration, each a medical services company. Mr. Papasan is also currently a Trustee or Director of SSR Engineering and Triumph Bankshares, Inc. Mr. Papasan was a former Trustee of First Funds mutual fund complex from 1992 to 2005, Chairman and President of Smith Nephew, Inc. from 1991 to 2002 and President of Memphis Light Gas and Water Division during his 28 year tenure. Mr. Papasan has further enhanced his experience and skills, in conjunction with the other Trustees, through the Boards ongoing oversight of the Fund officers in dealing with a diverse range of topics, to include but not limited to, portfolio management, legal and regulatory matters, compliance oversight, preparation of financial statements and oversight of the Funds multiple service providers. Mr. Papasan has served as Trustee for the Fund since its inception. Mr. Papasan also serves as a member of the Audit Committee and the Nominating and Corporationrationrate Governance Committee.
| Age | 79 |
| Tenure | 20 years |
| Phone | 800-975-8395 |
| Web | https://www.utilityincomefund.com/ |
Reaves Utility Management Performance (%)
The company has Return on Asset of 1.06 % which means that on every $100 spent on assets, it made $1.06 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.52 %, implying that it generated $2.52 on every 100 dollars invested. Reaves Utility's management efficiency ratios could be used to measure how well Reaves Utility manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
| Showing other executives | One Year Return | ||
| James Jacobson | Pimco Corporate Income | 75 | |
| James Howley | Guggenheim Strategic Opportunit | 47 | |
| Frank Gentile | Tekla Healthcare Investors | 62 | |
| Lisa Phelan | Cohen Steers Qualityome | 52 | |
| John Maney | Pimco Corporate Income | 62 | |
| Dr MS | Tekla Healthcare Investors | 71 | |
| Rakesh Jain | Tekla Healthcare Investors | 69 | |
| Randall Barnes | Guggenheim Strategic Opportunit | 68 | |
| Lisa Phelan | Cohen Steers Reit | 51 | |
| Stacie Anctil | Pimco Corporate Income | 51 | |
| William Ogden | Pimco Corporate Income | 75 | |
| Lisa Phelan | Cohen And Steers | 51 | |
| Kimberly Scott | Guggenheim Strategic Opportunit | 45 | |
| Ryan Leshaw | Pimco Corporate Income | 41 | |
| Lisa Phelan | Cohen Steers Total | 51 | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
| Mark Mathiasen | Guggenheim Strategic Opportunit | 41 | |
| James Jacobson | Pimco Corporate Income | 75 | |
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Amy Lee | Guggenheim Strategic Opportunit | 58 | |
| Dana Devivo | Cohen Steers Total | 39 | |
Management Performance
| Return On Equity | 2.52 | |||
| Return On Asset | 1.06 |
Reaves Utility If Leadership Team
Elected by the shareholders, the Reaves Utility's board of directors comprises two types of representatives: Reaves Utility inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reaves. The board's role is to monitor Reaves Utility's management team and ensure that shareholders' interests are well served. Reaves Utility's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reaves Utility's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mary Anstine, Independent Trustee | ||
| Jill Kerschen, Treasurer | ||
| Jeremy May, Chairman of the Board of Trustee and Presidentident | ||
| Larry Papasan, Independent Trustee | ||
| Edgar Nordberg, Independent Director, Trustee | ||
| Michael Holland, Independent Trustee | ||
| Jeremy Deems, Independent Chairman of the Board of the Trustee | ||
| Karen Gilomen, Secretary | ||
| Bradley Swenson, President | ||
| Theodore Uhl, Chief Compliance Officer | ||
| Kelly McEwen, Treasurer |
Reaves Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Reaves Utility a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.52 | |||
| Return On Asset | 1.06 | |||
| Profit Margin | 81.10 % | |||
| Operating Margin | 65.72 % | |||
| Current Valuation | 2.46 B | |||
| Shares Outstanding | 68.53 M | |||
| Shares Owned By Institutions | 10.15 % | |||
| Number Of Shares Shorted | 20.74 K | |||
| Price To Earning | 34.98 X | |||
| Price To Book | 0.89 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Reaves Fund
Reaves Utility financial ratios help investors to determine whether Reaves Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reaves with respect to the benefits of owning Reaves Utility security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |